Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives

Monica Iorfida, Manuelita Mazza, Elisabetta Munzone Division of Medical Senology, European Institute of Oncology, IRCCS, Milano 20141, ItalyCorrespondence: Elisabetta MunzoneDivision of Medical Senology, European Institute of Oncology, IRCCS, via Ripamonti 435, Milano 20141, ItalyTel +39 02 57489970...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Iorfida M, Mazza M, Munzone E
Format: article
Langue:EN
Publié: Dove Medical Press 2020
Sujets:
Accès en ligne:https://doaj.org/article/e694915222e5428886b3e22c2c99c156
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!